Legal News

Most Medicare providers and beneficiaries are unaware of the provision for comparative effectiveness research which is part of the Medicare Modernization Act. Politicians, policymakers, and manufacturers view it as a key initiative for the future of Medicare and beyond.

CMS announces accreditation deadlines for Part B DMEPOS suppliers

New rule requires pharmacies to provide patients with a toll-free number to report adverse events.

NACDS and NCPA win a key victory in their legal battle against the AMP rule when a federal judge issued a preliminary injunction against CMS

DEA proposes a rule that would create a new format for ordering Schedule I and/or II controlled substances.

Hospitals will not have to deduct pharmacy overhead costs from drug acquisition costs on Medicare claims, nor will they have to report overhead charges as a separate billing line item. However, CMS refused to back off its proposal to cut the 2008 reimbursement rate for all separately payable drugs.

The idea of a major new center to support studies comparing drugs and other medical interventions in head-to-head research has gained surprising focus in health policy discussions.

Participants at a recent roundtable meeting, including government and industry representatives, agreed to move forward with creating a forum on standardizing prescription medication labels.

Make the Road New York protests pharmacies for not providing translation services.

There are several reforms for emergency preparedness in the workds that could affect pharmacists.

The FDA has approved a new treatment for anthracycline extravasation. Totect is indicated for the treatment of extravasations resulting from IV anthracycline chemotherapy.

Pharmacy organizations celebrate American Pharmacists Month and look to raise awareness of the pharmacist's role in healthcare.

The Food and Drug Administration most emphatically is not against compounding of drugs, Steven Silverman, a key enforcement officer in that agency, told the National Association of Boards of Pharmacy recently.

Advice on the area of collaborative drug therapy managment.

The International Pharmaceutical Federation addressed progress in identifying and dealing with issues related to ersatz (or replacement) drug products.

The Centers for Medicare and Medicaid Services moves fowarded with implementing new tamper-restantant prescription pad rules.

DEA proposes self-certification fee for sellers of scheduled listed chemical products

California pharmacy board is stepping up its enforcement of its pharmacy consultation with stiffer fines.

The Senate passed legislation delaying implementation of the Medicaid rule mandating tamper-resistant Rx pads and awaits House action.

FDA's proposal for new sunscreen regulations address UVA rays as well as other measures consumers may take to protect themselves from UVB rays.

Medicare Part D was a remarkable development, not only for establishing a prescription drug benefit but for giving consumers more responsibility for their insurance and prescription purchase decisions.

New Jersey governor has signed a law that requires hospitals to test intensive care patients for a deadly staph infection.

Pennsylvania law requires reporting patient infections, and provides incentive payments when infection rates are successfully reduced.

A recent Institute for Safe Medication Practices teleconference with a surveyor from The Joint Commission highlighted the rigor with which TJC is implementing its medication management standards and National Patient Safety Goals.

Recent approvals have provided new options for treating kidney cancer. Updated guidelines will help utilize the new drugs.

Evidence-based guidelines and tools are available to help reduce mortality and length of stay; one major hurdle to conquering severe sepsis is having these tools readily available.

The 2006 U.S. incidence rate for tuberculosis is the lowest since the start of national records. But unless we are careful how we give medications out around the world, we could create caldrons of TB drug resistance a plane-ride awa

Pharmacist is indicted for manslaughter after medication error that results in the death of a two-year old girl.